|
1
|
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.
|
Proc Natl Acad Sci U S A
|
2014
|
1.53
|
|
2
|
An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
|
Dis Model Mech
|
2009
|
1.22
|
|
3
|
The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation.
|
Biochem J
|
2012
|
1.11
|
|
4
|
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
|
BMC Med
|
2012
|
1.10
|
|
5
|
Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS).
|
PLoS One
|
2010
|
1.05
|
|
6
|
A direct interaction between leucine-rich repeat kinase 2 and specific β-tubulin isoforms regulates tubulin acetylation.
|
J Biol Chem
|
2013
|
0.97
|
|
7
|
The SOD1 transgene in the G93A mouse model of amyotrophic lateral sclerosis lies on distal mouse chromosome 12.
|
Amyotroph Lateral Scler Other Motor Neuron Disord
|
2005
|
0.95
|
|
8
|
A test of static and dynamic balance function in children with cochlear implants: the vestibular olympics.
|
Arch Otolaryngol Head Neck Surg
|
2008
|
0.92
|
|
9
|
ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.
|
PLoS One
|
2010
|
0.87
|
|
10
|
Mutant glycyl-tRNA synthetase (Gars) ameliorates SOD1(G93A) motor neuron degeneration phenotype but has little affect on Loa dynein heavy chain mutant mice.
|
PLoS One
|
2009
|
0.82
|
|
11
|
Health-Related Quality of Life Among Young Children With Cochlear Implants and Developmental Disabilities.
|
Ear Hear
|
2017
|
0.75
|